Format
Sort by

Send to

Choose Destination

Search results

Items: 10

1.

Effects of 1-year treatment with highly purified omega-3 fatty acids on depression after myocardial infarction: results from the OMEGA trial.

Zimmer R, Riemer T, Rauch B, Schneider S, Schiele R, Gohlke H, Diller F, Steinbeck G, Katus H, Senges J; OMEGA-Study Group..

J Clin Psychiatry. 2013 Nov;74(11):e1037-45. doi: 10.4088/JCP.13m08453.

PMID:
24330904
2.

Risk factors for primary prevention of cardiovascular disease and risk reduction by lipid control: the OMEGA study risk factor sub-analysis.

Teramoto T, Kawamori R, Miyazaki S, Teramukai S, Mori Y, Okuda Y, Hiramatsu K; OMEGA Study Group..

Clin Exp Hypertens. 2014;36(4):236-43. doi: 10.3109/10641963.2013.810226.

PMID:
23865387
3.

Short-term comprehensive cardiac rehabilitation after AMI is associated with reduced 1-year mortality: results from the OMEGA study.

Rauch B, Riemer T, Schwaab B, Schneider S, Diller F, Gohlke H, Schiele R, Katus H, Gitt A, Senges J; OMEGA study group..

Eur J Prev Cardiol. 2014 Sep;21(9):1060-9. doi: 10.1177/2047487313486040.

PMID:
23559535
4.

Usefulness of heart rate to predict one-year mortality in patients with atrial fibrillation and acute myocardial infarction (from the OMEGA trial).

Li J, Becker R, Rauch B, Schiele R, Schneider S, Riemer T, Diller F, Gohlke H, Gottwik M, Steinbeck G, Sabin G, Katus HA, Senges J; OMEGA Study Group..

Am J Cardiol. 2013 Mar 15;111(6):811-5. doi: 10.1016/j.amjcard.2012.11.048.

PMID:
23276475
5.

Relationship between achieved blood pressure, dietary habits and cardiovascular disease in hypertensive patients treated with olmesartan: the OMEGA study.

Teramoto T, Kawamori R, Miyazaki S, Teramukai S, Shirayama M, Hiramatsu K, Kobayashi F; OMEGA Study Group..

Hypertens Res. 2012 Dec;35(12):1136-44. doi: 10.1038/hr.2012.93. Erratum in: Hypertens Res. 2012 Dec;35(12):1203.

6.

Sodium intake in men and potassium intake in women determine the prevalence of metabolic syndrome in Japanese hypertensive patients: OMEGA Study.

Teramoto T, Kawamori R, Miyazaki S, Teramukai S; OMEGA Study Group..

Hypertens Res. 2011 Aug;34(8):957-62. doi: 10.1038/hr.2011.63.

7.

OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction.

Rauch B, Schiele R, Schneider S, Diller F, Victor N, Gohlke H, Gottwik M, Steinbeck G, Del Castillo U, Sack R, Worth H, Katus H, Spitzer W, Sabin G, Senges J; OMEGA Study Group..

Circulation. 2010 Nov 23;122(21):2152-9. doi: 10.1161/CIRCULATIONAHA.110.948562.

8.

Highly purified omega-3 fatty acids for secondary prevention of sudden cardiac death after myocardial infarction-aims and methods of the OMEGA-study.

Rauch B, Schiele R, Schneider S, Gohlke H, Diller F, Gottwik M, Steinbeck G, Heer T, Katus H, Zimmer R, Erdogan A, Pfafferott C, Senges J; Omega-Study Group..

Cardiovasc Drugs Ther. 2006 Oct;20(5):365-75.

PMID:
17124558
9.

Nonnegligible increasing temporal trends in unprotected anal intercourse among men who have sexual relations with other men in montreal.

George C, Alary M, Otis J, Demers E, Remis RS, Mâsse B, Lavoie R, Vincelette J, Parent R, Leclerc R, Turmel B; Omega Study Group, Omega Cohort..

J Acquir Immune Defic Syndr. 2006 Jun;42(2):207-12. Erratum in: J Acquir Immune Defic Syndr. 2006 Aug 1;42(4):521.

PMID:
16645547
10.

No increase in HIV incidence observed in a cohort of men who have sex with other men in Montreal.

Remis RS, Alary M, Otis J, Mâsse B, Demers E, Vincelette J, Turmel B, LeClerc R, Lavoie R, Parent R, George C; Omega Study Group..

AIDS. 2002 May 24;16(8):1183-5.

PMID:
12004279
Items per page

Supplemental Content

Loading ...
Support Center